-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Introduction: The new crown has continued so far, human beings have paid a tragic price, and many people are anxious about when the epidemic will be a head.
The WHO released the latest realistic data
WHO: New COVID-19 cases drop by 25%
On August 17, the World Health Organization (WHO) released a report on the COVID-19 outbreak, showing that the number of COVID-19 cases reported globally fell by 25% last week, and the number of deaths fell by 6%, but the number of COVID-19 deaths in parts of Asia is still at a high level (Figure 1
The number of COVID-19 cases reported globally fell by 25% last week and deaths fell by 6%, but the number of COVID-19 deaths in parts of Asia remains at a high level
Figure 1 Report of the World Health Organization (Source: [1])
1 Global region: New cases continue to decrease, with new deaths concentrated in the Asia-Pacific region
Global region: New cases continue to decrease, with new deaths concentrated in the Asia-Pacific regionAs of 14 August 2022, 587 million confirmed cases and 6.
Weekly number of new cases reported in all six regions of the world increased weekly new deaths in the Western Pacific (+31%) and South-East Asia (+12%)
Figure 2 Weekly reporting of COVID-19 cases and global deaths in the WHO Region as of 14 August 2022 (Source: [1])
2 National level: South Korea has the highest new case increase rate, and Japan has the highest new death rate
2 National level: South Korea has the highest new case increase rate, and Japan has the highest new death rateAt the national level, the countries with the highest number of new cases reported each week are: The Republic of Korea (866,830 new cases; +22%), Japan (1395301 new cases; -7%), new cases in the United States (679653; -14%), Germany (271277 new cases; -25%) and Italy (193305 new cases; -32%)
Korea +22% Japan 64%
Table 1 New reports and cumulative confirmed covid-19 cases and deaths in WHO regions as of 14 August 2022
Table 1 New reports and cumulative confirmed covid-19 cases and deaths in WHO regions as of 14 August 2022
Source: [1] | Draft: Bio Exploration Editorial Team
Figure 3 Covid-19 case reports per 100,000 population by country, region and region from 8 to 14 August 2022 (Source: [1])
3 The world's mainstream infection with THE NEW CROWN variant strains: BA.
3 The world's mainstream infection with THE NEW CROWN variant strains: BA.
Figure 4 Number and percentage of global SARS-CoV-2 sequences as of August 15, 2022 (Source: [1])
The genetic diversity of BA.
Table 2 Relative proportions of BA.
Table 2 Relative proportions of BA.
Source: [1] | Draft: Bio Exploration Editorial Team
4 Vaccine effectiveness: Ve was significantly reduced in all vaccines when faced with the Omicron variant
4 Vaccine effectiveness: Ve was significantly reduced in all vaccines when faced with the Omicron variantTo date, 37 studies from 15 countries (Argentina, Brazil, Canada, Chile, Czech Republic, Denmark, Finland, Norway, Israel, Qatar, Singapore, South Africa, United Kingdom, United States of America and Zambia) have collectively evaluated the protective effects
Compared to the original COVID-19 strain and the four previously transmitted variants, the COVID-19 vaccine has significantly reduced VE protection against severe diseases, symptomatic diseases and infections when confronted with the Omicron variant
Table 3 Summary of research on vaccine efficacy for Omicron's variant of interest
Table 3 Summary of research on vaccine efficacy for Omicron's variant of interest
Source: [1] | Draft: Bio Exploration Editorial Team
Note: EUL (Emergency Use Listing) represents emergency use list, HNR (high non-response) indicates high non-response, and the median percentage response of all studies <75%.
For severe cases, VE hardly decreased
In all studies, the first booster dose vaccination improved VE for severe disease, with 37 (95%) of the 39 estimates of VE between 14 days and 3 months of receiving the booster dose ≥ 70%.
The pace of mutation of the new crown virus will not stop, and the direction of mutation is beyond human control
The vast majority of people in our country do not have immunity to the new crown virus, are susceptible to the new crown virus, and after the onset of infection, some people will develop critical illness and even cause death
Resources:
Resources:[1]
[1]